Refine
Document Type
- Doctoral Thesis (2)
Language
- English (2) (remove)
Has Fulltext
- yes (2)
Is part of the Bibliography
- no (2)
Keywords
- herpesvirus (2) (remove)
Institute
Herpesviruses are enveloped DNA viruses which are dependent on two fusion steps for efficient replication in the host cell. First, they have to fuse their envelope with the cellular plasma membrane or with the vesicle membrane after endocytic uptake to enter the host cell and second, they have to export the newly generated nucleocapsids from the site of assembly to the cytoplasm by fusion of the primary virion envelope with the outer nuclear membrane (ONM). The main goal of this project was to provide a better understanding of how herpesvirus capsids exit the nucleus. On the one hand this thesis aimed at finding cellular proteins involved in nuclear egress (Paper I), while on the other the focus was on further characterization of the viral nuclear egress complex (NEC, Paper II) and its interaction with the capsid (Paper III).
It is the hallmark of viruses, including herpesviruses, to hijack host cell proteins for their efficient replication. Some of those interactions are well characterized, while others might not yet have been discovered. In the last step of the nuclear egress, where the primary virion membrane fuses with the ONM, most likely a cellular machinery is involved. The presented work focused on Torsin, the only known AAA+ ATPase localizing in the endoplasmic reticulum and the perinuclear space (PNS). For this, the effect of overexpression of WT and mutant proteins, as well as CRISPR/Cas9 generated knock-out cell lines, on PrV replication was analyzed. Neither single overexpression nor single knockouts of TorA or TorB had any significant effects on virus titers. However, infection of TorA/B double knockout cells revealed reduced viral titers and an accumulation of primary virions in the PNS at early infection times, indicating a delay in nuclear egress.
The process of nuclear egress has been intensively investigated without revealing all its details. To address some of the missing aspects we generated monoclonal antibodies (mAbs) against the NEC and its components (pUL31 and pUL34) for a better visualization of the process in transfected as well as infected cells. These mAbs provide a useful tool for future analyses.
The publication of the NEC crystal structure formed the basis for intensive research on the molecular details of the NEC formation and its interaction with the nucleocapsid. Recently, our lab showed that lysine (K) at position 242 in the membrane-distal part of pUL31 is crucial for incorporation of the nucleocapsid into budding vesicles. Replacing K by alanine (A) resulted in accumulations of vesicles in the PNS, while mature capsids were not incorporated. To test whether this is due to electrostatic interference or structural restrictions we substituted K242 by different aa to determine the requirements for nucleocapsid uptake into the nascent primary particles. To analyze whether the defect of pUL31-K242A can be compensated by second-site mutations, PrV-UL31-K242A was passaged and mutations in revertants were analyzed. Different mutations have been identified compensating for the K242A defect. A considerable number of mutations indicates that the NEC is much more flexible than previously thought. Further, we gained information that the K at position 242 is not directly involved in capsid interaction, while it is more likely involved in rearrangements within the NEC coat.
Herpesviruses are a fascinating group of enveloped DNA viruses, which rely on membrane fusion for infectious entry and direct cell-to-cell spread. Compared with many other enveloped viruses, they utilize a remarkably complex fusion machinery. Three conserved virion proteins, the bona fide fusion protein gB, and the presumably gB activating gH/gL heterodimer constitute the conserved core fusion machinery and are believed to drive membrane fusion in a cascade-like fashion. Activation of this cascade in most alphaherpesviruses is proposed to be triggered by binding of gD to specific host cell receptors. The molecular details of this fusion process, however, remain largely elusive. Yet, a detailed mechanistic knowledge of this process would be greatly beneficial for the development of efficient countermeasures against a variety of diseases. In this thesis, the functional relevance of individual components of the essential gH/gL complex of the alphaherpesvirus PrV has been assessed by two different approaches: by reversion analysis (paper II) and site-directed mutagenesis (papers III-V). In contrast to other herpesviruses, gL-deleted PrV is able to perform limited cell-to-cell spread, providing the unique opportunity to passage the entry-deficient virus in cell culture to select for PrV revertants capable of infecting cells gL-independently. This approach already resulted in an infectious gL-negative PrV mutant (PrV-ΔgLPass), in which the function of gL was compensated by formation of a gDgH hybrid protein. Here, the requirements for gL-independent infectivity of a second independent revertant (PrV-ΔgLPassB4.1), were analyzed. Sequencing of the genes encoding for gB, gH and gD, revealed mutations in each of them. By means of a robust infection-free, transfection-based cell-cell fusion assay (paper I), we identified two amino acid substitutions in the gL-binding domain I of gHB4.1 (L70P, W103R) as sufficient to compensate for lack of gL. Two mutations in gB (G672R, ΔK883) were found to enhance fusogenicity, probably by lowering the energy, required for gB refolding from pre- to postfusion conformation. Coexpression of gHB4.1 and gBB4.1 led to an excess fusion, which was completely suppressed by gDB4.1 in the fusion assays. This was surprising since PrV gD is normally not required for in vitro fusion or direct viral cell-to-cell spread, clearly separating this process from fusion during entry, for which PrV gD is essential. The fusion inhibiting effect of gDB4.1 could be attributed to a single point mutation resulting in an amino acid substitution within the ectodomain (A106V). In conclusion, these results indicated that gL is not central to the fusion process, as its function can be compensated for. As found so far, gL-independent infectivity can be realized by compensatory mutations in gH (as in PrV-ΔgLPass) or in gH plus gB (as in PrV-ΔgLPassB4.1). Excessive fusion induced by gHB4.1 and gBB4.1 was counter-regulated by gDB4.1, indicating that the interplay between these proteins is precisely regulated and further implies that gL and gD, despite being not absolutely essential for the fusion process, have important regulatory functions on gH and/or gB.
Both PrV-ΔgLPass mutants had acquired compensatory mutations in gH affecting the predicted gL-binding domain I in gH. By construction of an artificial gH32/98, which lacked the predicted gL-binding domain and was similar to the recently crystallized gH-core fragment present in the gDgH hybrid protein, we identified the N-terminal part of PrV gH as essential for gH function during fusion (paper III). gH32/98 was unable to promote fusion of wild-type gB in fusion assays and led to a total loss of function in the viral context. These results indicated that the gD moiety, present in gDgH, is critical for proper function of the gH-core fragment. We hypothesize that the gD moiety may adopt a stabilizing or modulating influence on the gH structure, which is normally executed by gL and important for interaction of gH with wild-type gB. Remarkably, substitution of wild-type gB by gBB4.1 rescued function of gH32/98 in the cellular and viral contexts. These findings suggest that gBB4.1 has been selected for interaction with “gL-less” gH. In conclusion, these results demonstrated that gL and the gL-binding domain are not strictly required for membrane fusion during virus entry and spread but that compensatory mutations must be present in gB to restore a fully functional fusion machinery. These results strongly support the notion of a functional gH-gB interaction as a prerequisite for membrane fusion.
In addition to the N-terminal domain, we identified the transmembrane domain of PrV gH as an essential component of the fusion machinery, while the cytoplasmic domain was demonstrated to play a modulatory but nonessential role (paper IV). Whereas truncation or substitution of the PrV gH TMD by a gpi-anchor or the analogous sequence from PrV gD rendered gH non-functional, the HSV-1 gH TMD was found to functionally substitute for the PrV gH TMD in cell-cell fusion and complementation assays. Since residues in the TMD which are conserved between HSV and PrV gH but absent in PrV gD, are placed on one face of an α-helical wheel plot, we hypothesize that the gH TMD has an intrinsic property to interact with membrane components such as lipids or other molecules as a requirement for promoting membrane fusion.
In a final study focusing on the function of gH, we identified the N-glycosylation sites utilized by PrV gH, and determined their individual role in viral infection (paper V). PrV gH was found to be modified by N-glycans at five potential glycosylation sites. N-glycans at PrV specific N77 and the highly conserved site N627 were found to be critical for efficient membrane fusion in the fusion assays, and during viral entry and cell-to-cell spread. N627 was further shown to be crucial for proper gH transport and maturation. In contrast, inactivation of N604, conserved in the Varicellovirus genus, enhanced in vitro fusion activity and viral cell-to-cell spread. These findings demonstrated a role of the N-glycans in proper localization and function of PrV gH.